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ABSTRACT 
Zhang, Ximo. Ph.D., Purdue University, August 2016. Protein LC-MS Using Slip Flow 




Histones are essential chromosomal proteins with large numbers of variants and 
post-translational modifications (PTMs). PTM levels of histones are known to correlate 
with different stages of cancer. Due to the lack of resolution on intact histone separations, 
conventional methods for histone analysis require time-consuming digestion, which often 
leads to the loss of PTM information. Slip flow chromatography with orderly packed 
nonporous silica particles has been shown to greatly increase the efficiency of protein 
separation by reducing eddy diffusion and resistance to mass transfer. In this work, 
higher resolution for intact histones separation was achieved by using a 5 cm capillary 
with 470 nm particle size and C18 bonded phase. The levels of histone phosphorylation 
and other PTMs were verified by deconvoluted MS spectra. This methodology was also 
applied to the separation of a complex mixture of protein digests. A peak capacity of 500 
was achieved by using a 30 min gradient elution. Other bonded phases such as C4 and 
TDP were also developed to separate different protein samples. This dissertation also 
includes 1) separation of intact monoclonal antibodies by RPLC; 2) characterization of 
reduced monoclonal antibodies by nano-RPLC-MS; 3) analysis of ubiquitin and ubiquitin 
   xiii 
linker in a new pathway of ubiquitination; 4) separation of RRM2 monomer and 
aggregates. Above results demonstrated the effectiveness of slip flow capillary for the 
separation of both protein and peptide separation for proteomic studies.  
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CHAPTER 1: INTRODUCTION 
1.1 Challenges in Biopharmaceutical Research and Development  
The biopharmaceutical industry has become one of the fastest growing divisions 
in global market in the past two decades. From 2000 to 2012, many large pharmaceutical 
companies had an increasing percentage of revenue contributed from 
biopharmaceuticals.[1] Common biopharmaceutical drugs, also known as biologics, 
include engineered antibodies,[2] recombinant therapeutic proteins and genetic materials. 
Compared to traditional small molecule drugs, biopharmaceutical drugs provide higher 
efficacy and fewer side effects. In addition, the structural complexity of 
biopharmaceutical drugs makes it difficult to manufacture generic products and therefore 
protects brand-name drugs. These favorable features assure the continuous growth of 
biologics in the pharmaceutical market in the future. 
 The development of biopharmaceuticals is not without challenges. [2] One major 
obstacle is the detailed characterization of drug candidates. Before sending any 
therapeutic drugs to clinical trials, many aspects of chemical and physical properties of 
the candidate drugs must be fully characterized and controlled, including the drug 
efficacy, purity and stability.[2, 3] For biopharmaceutical drug development, proteins are 
the major targets. Unlike small molecule drugs, proteins have much larger molecular 
weights and more complexed three dimensional structures.[4] Monoclonal antibodies, 
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which are a common kind of therapeutic protein, have a mass of 150 kDa. The 
complexity of protein structures increases the difficulty of drug analysis.[5] In addition, a 
small difference in protein structure or conformation can lead to a large change in 
biological function and thus require more detailed analysis.[6] For example, post-
translational modifications (PTMs) on histones are related to various cellular responses. 
Heterogeneity in disulfide bonds results in different stability of monoclonal antibodies. 
Glycosylation of a monoclonal antibody can affect drug efficacy. As the number of drug 
targets grows quickly, it is essential to develop higher efficiency analytical methods for 
protein characterization.  
Starting in 1975 with 2D-PAGE for protein profiling, proteomics has become a 
widely used tool in many areas of biopharmaceutical drug development,[7-10] including 
the analysis of targeted protein expression, sub-proteome enrichment and preclinical or 
clinical studies.[11, 12] With MS based detection methods, proteins with no available 
immunoassay can be detected and identified, which promotes the discovery and follow-
up studies of both protein targets and biomarkers.[13, 14]  
Proteomics can be categorized as bottom-up, middle-down and top-down 
proteomics. Bottom-up proteomics uses an enzyme, usually trypsin, to produce small 
lengths of peptides, followed by separation and detection.[15] Separation of peptides is 
usually easier compared to intact proteins, and the databases for protein identification are 
also well developed.[16] Nowadays, bottom-up proteomics has been routinely used in 
drug development as an essay for protein identification. However, the time consuming 
sample preparation process increases the cost and labor. There is also risk of losing PTM 
information during the digestion and identification process. Middle-down proteomics is 
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to reduce the proteins to relatively larger fragments compared to peptides, and then 
perform the analysis. This method is especially useful for large protein analysis, such as 
monoclonal antibodies. Top-down proteomics is the analysis of intact proteins. 
Theoretically, all PTMs including their localization information are well preserved with 
top-down proteomics.[17, 18] Moreover, since there is very little sample preparation 
required, top-down proteomics can be considered as a high-throughput analytical method. 
The bottleneck of top-down proteomics is separation technology.[19, 20] Currently a 
protein separation requires long analysis time and large sample size, or suffers from poor 
resolution and sensitivity.[21] Therefore, it is essential to improve separation 
technologies for analysis of proteins. 
1.2 Protein Separation Technologies 
Current protein separation technologies used in biopharmaceutical industry and 
related academic areas are mainly based on immunoprecipitation[22], HPLC and 
electrophoresis.[4, 23-27] Different separation technologies are applied to meet the 
requirements of different stages of drug development.[21] Immunoprecipitation is 
commonly used for protein extraction and purification, while HPLC and electrophoresis 
are used in almost every aspects of biopharmaceuticals, including drug discovery, process 
development and quality control. [28] 
LC based technologies are suitable for various stages of protein separation based 
on different mechanisms.[29, 30] Reversed phase liquid chromatography (RPLC) is the 
most widely used method for protein separation since the denatured proteins are 
hydrophobic in acidic mobile phases.[31] Based on the difference of overall 
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hydrophobicity, proteins can be separated by interacting with the hydrophobic stationary 
phases. Hydrophobic interaction chromatography (HIC) is another method that also based 
on hydrophobicity. The advantage of HIC is that it does not denature the proteins since 
the mobile phases used for HIC are water based, giving orthogonal selectivity compared 
to RPLC by separating based on the outer amino acids. The major application of HIC is 
separation of antibody-drug-conjugates due to the non-covalent binding among antibody 
subunits.[32, 33]  Ion exchange chromatography (IEX) is a charged based separation 
method for analysis of protein charge heterogeneity.[34] Hydrophilic interaction 
chromatography (HILIC) is usually used for separation of proteins with glycosylation.[35, 
36] In order to achieve higher resolution for protein separations, current strategies are to 
combine two separation methods with different mechanisms to perform 2D separation. 
Therefore the peak capacity can be greatly enhanced. In addition to being used as 
detector for protein identification, mass spectrometer can be considered as another 
separation dimension for complexed sample analysis.[37, 38] In this case, the separation 
methods with salt-containing mobile phases, such as HIC and IEX, are often used as the 
first dimension of separation to avoid immiscibility of solvents. [39] 
Electrophoresis, including 2D-PAGE[40], CZE[41-44] and cIEF[45, 46], has been 
widely used for protein separation with the well-developed automated instrumentation. 
[47, 48] Electrophoresis can also be combined with LC for 2D separation of proteins and 
provide very high resolution.[49, 50] However, the analysis time of traditional 
electrophoresis, such as 2D-PAGE is much longer than common LC separation, which 
limits the use of electrophoresis in industry.  
   5 
Fast development of biopharmaceutical industry calls for better separation 
technologies. With the growing number and complexity of protein samples, it is essential 
to develop separation methods with higher resolution and throughput. Beyond increasing 
the number of dimensions for protein separation, the separation power and speed of each 
dimension has to be improved.  
1.3 Research Objective 
The objective of this research is to develop highly efficient LC-MS methods for 
protein separations. The approach is to use modified submicrometer nonporous silica 
particles as stationary phase to reduce the plate height of protein peaks. The low plate 
height of protein peaks leads to high resolution, which enables the use of a shorter 
column length for separation while still providing higher resolution. Therefore, the 
analysis time is shortened in addition to resolution improving. 
This study was conducted in three phases. The first phase is to improve and adapt 
slip flow capillary column for LC-MS of proteins, then develop methods for a specific 
group of proteins. Histones are chromatin proteins with double-stranded DNA wrapped 
around. The post-translational modifications (PTMs) of histones are reported to relate to 
various epigenetic diseases. In order to utilize histones PTMs as biomarker and develop 
treatments for epigenetic diseases, high-resolution separation of histone variants is 
essential for further study of the PTMs on histones. In this work, the first focus will be to 
develop LC-MS methods for histones with the use of C18 slip flow capillary, which is 
described in Chapter 3. The second phase is to demonstrate the capability of C18 slip 
flow capillary on peptides separation due to the necessity of peptides separation as an 
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assay in drug development. Chapter 4 discussed the fundamental theory and the 
experimental results of peptides separation. The last phase is to develop LC-MS methods 
for other protein samples with masses ranging from 8 kDa to 150 kDa. Multiple kinds of 
bonded phases are adapted for the separation of different samples. The separation of these 
protein samples, including ubiquitin, RNA recognition motif (RRM2), reduced and intact 
monoclonal antibodies (mAbs), is detailed in Chapter 5. In Chapter 6, the possibility of 
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CHAPTER 2: SUBMICROMETER PARTICLES FOR PROTEIN SEPARATION 
Part of this Chapter is adapted from  
B.A. Rogers, Z. Wu, B. Wei, X. Zhang, X. Cao, O. Alabi, M. J. Wirth, Anal. Chem. 
2015, 87(5), 2520-2526 
2.1 Nonporous Silica Particles 
The efficiency of liquid chromatographic separations has continuously improved 
over the last 2 decades, giving higher speed and resolution.[1, 2] Two advances have 
contributed. The first is the use of porous particles as small as 1.7 μm, which reduces the 
distance over which mass transport occurs. These smaller particles have necessitated 
higher pressure pumps,[3] which ushered in the term “ultra-performance liquid 
chromatography”, UHPLC. The other advance is the use of core?shell particles, which 
have a solid core having a thin shell of porous particles on the outside.[4] The fully 
porous and the core?shell particles are depicted schematically for comparison in Figure 
1, showing that each is comprised of uniform, nonporous colloidal silica particles 
aggregated to achieve the desired morphology. A shell thickness of half of 1.7 μm gives a 
comparable advantage to that of the 1.7 μm fully porous particles but without the need for 
the higher pressure pump. Sub-2-μm core?shell particles give even higher efficiency, 
with thinner shells giving higher speed and better resolution. The core?shell particles 
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have been widely adopted by the pharmaceutical industry for analysis of small-molecule 
drugs. Figure 2.1 also depicts a nonporous silica particle, and this article discusses how 
nonporous particles promise a further advance when they are submicrometer in diameter. 
As exciting as the sub-2-μm and core?shell particles have been for separations of 
small molecules, they do not fully address what is perhaps the most pressing need in 
separations: proteins.[5] Protein drugs, particularly therapeutic monoclonal antibodies, 
represent the fastest growing segment of the pharmaceutical industry.[6] Liquid 
chromatography is indispensable for characterizing composition of small-molecule drug 
substances, and for proteins the task is all the more difficult due to the multiplicity of 
post-translational modifications, oxidation of methionine groups, disulfide scrambling, 
fragmentation, aggregation, and other processes that change the protein sample. Top-
down proteomics is another area where better separations of intact proteins are needed[7] 
because insufficient resolution requires multiple dimensions of separations. This chapter 
explores why smaller particles and thinner shells have not impacted protein separations 
more significantly than they have and how the nonporous submicrometer particles 
2.2 Smaller Particle Size Reduces Plate Height 
The gradual development of smaller particles and thinner shells has been guided 
by the role these play is reducing the broadening of peaks. The van Deemter equation is a 
simple way of describing this role. The plate height, H, is a measure of peak variance 
normalized for separation length. Smaller H is thus better. The van Deemter equation is 
expressed as H vs. velocity, ?, which is the mobile phase inside the separation medium. 
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The equation illustrates that smaller particle diameter, dp, gives a smaller plate 
height by affecting both the first and third terms. Diffusion is described by the diffusion 
coefficient, D. The term A is a measure of the radial heterogeneity of the packing density. 
The term 2?D is referred to as the B term, where ? is the factor by which the diffusion 
along the separation axis is obstructed by the solid particles, and D is the diffusion 
coefficient. The term Cpores is the factor by which the diffusion in and out of the porous 
medium is obstructed by the solid particles. There are also extra-column contributions, 
e.g., the nonzero injection and detection volumes, the parabolic flow profile through the 
tubing, and any broadening from the frits and the geometric effects of the column itself. 
Two other C terms can contribute but are neglected. One is Cm, which results from the 
parabolic flow profile between particles. It plays the same role with respect to particle 
size as Cpores. The other is Cs, which is related to the desorption time of the analyte from 
the stationary phase. These terms are left out because they usually give smaller effects 
that would needlessly complicate the discussion of why smaller particle diameter reduces 
broadening in liquid chromatography.  
To illustrate how much can be gained from smaller particle diameter, or thinner 
shell of a core?shell particle, van Deemter plots for varying particle sizes are provided in 
Figure 2.2 a for the case of small-molecule separations. The curves were generated by 
fitting published van Deemter plots for 5 μm particles to recover A, B, and C.[8] The 
synthetic curves show that the minimum plate heights are on the order of twice the 
particle diameter, hence the advantage of smaller particles. The magenta line is the 
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projected curve for the hypothetical case of fully porous particles of 0.5 μm in diameter, 
calculated using the Kozeny?Carman equation.[9] While it reduces plate height by 
another factor of 2, the pressure is unreachable. Current UHPLC instruments would give 
a mobile phase velocity of less 0.2 cm/s for the 0.5 μm particles in a column of these 
dimensions, thus giving no advantage over the 1.7 μm particles currently used. These 
curves also depict the general behavior of core?shell particles having shell thicknesses of 
half the particle diameter. In other words, the diffusion distance for a 0.5 μm shell 
thickness is equivalent to a 1 μm fully porous particle. The shell can be arbitrarily thin 
without adding to the pump pressure, but ultimately, the surface area of the stationary 
phase would give insufficient retention. It should be noted again that equation to generate 
these curves does not include any broadening from the instrument, Hec, in eq 1, and it 
does not include slow kinetics of desorption that might occur with some samples. The 
curves suggest that current technology is approaching the optimum for both porous and 
core?shell particles in separations of small molecules; little is to be gained in going with 
smaller diffusion distances.  
For proteins, the picture is changed markedly because of the much larger 
molecular size of the protein, slowing the diffusion by an order of magnitude. Synthetic 
van Deemter curves for a protein with a 10-fold slower diffusion coefficient than the 
small-molecule are shown in Figure 2.2 b. The optimal flow rate is now much lower, 
giving a potentially huge advantage in using 0.5 μm particles. The achievable pressure of 
modern instruments, which is 17500 psi, would give a velocity of 0.05 cm/s for 0.5 μm 
particles and these column dimensions, resulting in about a 5-fold smaller plate height. 
For core?shell particles, a shell thickness of 0.25 μm is projected to give this same 
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advantage, and longer column lengths could be used because back-pressure is much less 
of an issue.  
2.3 Slip Flow Effect Alleviated Back Pressure  
Nonetheless, we studied pressure-driven protein chromatography in capillaries 
packed with silica colloidal crystals. The results surprised us in two ways: the back-
pressure was much lower than is predicted[10] and the plate height was very much lower 
than is predicted.[11] Both were pleasant but confounding surprises. We now understand 
why the back-pressure is reduced: the phenomenon known as slip flow is occurring.[12, 
13] The chromatography textbooks had taught us that the velocity of the mobile phase 
goes to zero at the wall, whereas in fluid dynamics this would be presented as the “no-
slip” boundary condition. In reality, the velocity would be zero at the wall only if the 
attractive interactions between the mobile and stationary phase molecules were exactly as 
strong as those between the mobile phase molecules themselves. This is far from the case 
for RPLC since the functional groups on the surface have been chosen to be hydrophobic, 
giving little interaction with the mobile phase in reversed-phase liquid chromatography. 
Consequently, the velocity of the mobile phase at the wall is nonzero.  
With slip flow, the average velocity, ??slip?, is increased from the conventionally 
expected velocity, ??no-slip?, by an additive amount from the nonzero velocity at the wall, 
?wall.  
slip no slip wallv v v?= +  
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This additive relation is illustrated in Figure 2.3 a. Note that the velocity profile is 
parabolic profile for both the slip and no-slip cases and that there is simply an additive 
term in the slip case due to the velocity at the wall. For the case depicted in Figure 2.3 a, 
the average velocity is a factor of 4 higher than that for the no-slip case. Because the 
parabolic profiles are the same for the slip and no-slip cases, the relative velocity 
distribution is narrower for the slip case.  
Submicrometer particles can give high flow enhancements because of the nonzero 
wall velocity. Figure 2.3 b shows the experimentally measured flow enhancements for a 
wide variety of particle diameters, ranging from 0.12 to 1.3 μm, all for nonporous 
particles with C4 bonded phases and a mobile phase of water.[9] The data show that the 
flow rate enhancement depends on particle diameter, and the enhancement becomes small 
for particle diameters about a micrometer. This may seem perplexing at first because the 
wall velocity is related to the fluid?surface interactions, not the particle size. In fact, the 
wall velocity is the same regardless of particle size, but wall velocity has a bigger impact 
on the overall flow rate when the velocity in the middle of the stream is smaller. 
Consequently, slip flow is only noticed when the walls are very close together. The 
relation between interstitial dimension and flow enhancement is described 
mathematically by the geometry depicted in Figure 2.3 a, where a tangent is drawn to the 
parabola at the fluid?surface boundary. This tangent is (d?/dr)wall, and the red triangle in 
the figure shows that this is the ratio of the velocity at the wall to the so-called slip 
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The slip length is what is fixed by the fluid surface interactions, with longer slip 
lengths giving higher flow enhancements. It was shown by Navier in 1823 that the 
volume flow rate (or the average velocity) is enhanced for fluid flowing through a 
capillary according to the slip length and the capillary radius, r. 
41 sslip no slip
Lv v
r?
?? ?= +? ?
? ?
 
The solid curve in Figure 2.3 b is a plot of this equation, using the effective 
hydrodynamic radius of the packed bed calculated from fluid dynamics,[14] and the best 
fit reports a slip length of Ls = 63 ± 3 nm. This value is in agreement with the range of 
values estimated from previous studies of water?hydrocarbon surfaces, albeit much more 
precisely determined. The enhancement of 5-fold in flow rate for the 0.5 μm particles 
enables use of the same 5?10 cm column lengths widely used for protein 
chromatography. 
2.4 Nano-LC-MS of Intact Proteins 
Previous work, performed by Wu et al., has demonstrated high efficiency of 
protein separation of chromatography.[15] Slip flow chromatography can be used with 
LC-MS for protein characterization. To avoid post column broadening, the end of 
capillary was pulled to a tip to directly couple to mass spectrometer. For nano-LC-MS, 
470 nm nonporous silica particles were packed into a 100 μm i.d. fused silica capillary to 
separate intact proteins. The capillary was modified via horizontal polymerization in 
order to immobilize the particles inside of the capillary. A mixture of intact proteins, 
including ribonuclease A, trypsin inhibitor, carbonic anhydrase and ubiquitin was studied 
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as a standard protein sample. Results showed the fast speed and narrow peak widths of 
proteins. With a 10 min gradient, a peak capacity of 195 was obtained by a 4 cm capillary. 
Besides peak capacity, high sensitivity and reproducibility were also achieved. The 
injection amounts were as low  
 
as 1 fmol while high signal to noise ratio was still shown for the mass spectra of proteins, 
and all protein peaks showed less than 0.3% RSD for peak width. [15] This high 
efficiency of protein separation indicates the potential of using slip flow capillary on top 
down proteomics. 
2.5 Instrument Contribution to Protein Separation 
Most chromatographic columns are commercialized in stainless steel format for 
UV?visible detection. This format is widely used for quality control in the 
pharmaceutical industry because most organic drugs impurities will give absorbance at 
210 nm. Further, not all impurities are detectable by mass spectrometry, and UV 
detection gives better quantitative reproducibility. Capillaries have short path lengths, 
limiting the sensitivity of UV detection. This raises the question of whether one can gain 
any advantage with submicrometer particles in stainless steel columns. The best UHPLC 
instruments contribute approximately 10 μL in dispersion volume, giving a 5.6 mm base 
width for a 2.1 mm i.d. column. This is enormous compared to the broadening from 
capillaries. The comparison is summarized visually in Figure 2.4 to illustrate how much 
is lost in going from capillaries to stainless steel columns. Contributions from the 
instrument include the parabolic flow profile through the tubing and the detector volume. 
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Since columns do contribute broadening beyond the instrument contribution due to 
packing heterogeneity, the homogeneity of packed submicrometer particles could still 
have an impact. NanoLC instruments might begin competing in this arena since 
sensitivity is greatly enhanced from less peak broadening. The short path length across a 
capillary could be fully offset by the  
 
narrower peak width to give comparable sensitivity. Given the potential for such higher 
resolution without sacrificing sensitivity of UV absorbance, nanoLC might have a bright 
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Figure 2.4. Illustration of how much broadening is currently imparted by commercial 
instruments. These are plots of Gaussians to help visualize (1) the 64 μm base width for 
no instrument contribution vs (2) the ?400 μm base width in typically images observed 
using a nanoLC for injection with MS for detection vs (3) the 2.5 mm base width 
calculated for the current best-performing UHPLC instrument with a 5.5 μL dispersion 
volume, considering no contribution from the column. All base widths are for peaks 
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CHAPTER 3: LC-MS OF INTACT HISTONES USING SLIP FLOW 
CHROMATOGRAPHY 
3.1 Introduction 
Histones, including core histones (H2A, H2B, H3 and H4) and linker histones 
(H1), are basic chromosomal proteins that are involved in many physiological processes 
mostly through its post-translational modifications (PTMs).[1, 2] These PTMs, which 
chiefly include phosphorylation, methylation, acetylation and ubiquitination,[3] can work 
individually or in concert to generate a ‘histone code’ that participates in the regulation of 
various cellular responses such as gene transcription and DNA repair.[1, 4, 5] Recent 
studies showed that the levels of histone PTMs can be correlated to different stages of 
cancer.[6, 7] Therefore, understanding the function and mechanism of histones PTMs 
could benefit early diagnosis and treatment for various diseases. However, the analysis of 
PTMs in intact histones is difficult due to the large number of histone variants that may 
differ by only a few amino acid sequences.[2] On the other hand, conventional methods 
such as bottom-up proteomics risk losing PTMs information in the digestion processes.[8, 
9] Therefore, characterization of intact histones is essential to fully understand and utilize 
histone PTMs as biomarkers for cancer diagnosis. 
Top-down proteomics has been proven to be an effective method for intact 
histones analysis because one must characterize multiple PTMs on the same protein.[9, 
10] Kelleher and coworkers discovered 42 forms of H4 histones through the use of an 
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offline RPLC-HILIC-FTMS.[11] With RPLC-MS, Su et al. completed the profiling of 
whole histones and the PTMs including methylation and acetylation.[12] Contrepois et al. 
developed a method to characterize core histone variants and PTMs in 20 min via RPLC-
LTQ-Orbitrap.[13] However, owing to the poor chromatographic resolution of histone 
variants, these LC-MS methods suffer from laborious fractionation and long analysis 
time. Methods that use a faster gradient to reduce analysis tine would otherwise sacrifice 
the resolution and increase the complexity of mass spectra. Hence, higher efficiency of 
separations are desired for intact histones in top-down proteomics. 
With uniformly packed 0.5 μm silica nanoparticles, slip flow chromatography has 
significantly advanced the efficiency of intact protein separations via reduced particle 
size and slip flow enhancement.[14-16] The purpose of this work is to test whether this 
advance benefits top-down proteomics analysis of intact histones.  
3.2 Material and Methods 
3.2.1 Materials 
HPLC grade water, acetonitrile, formic acid, TFA, DFA and histones from bovine 
calf thymus were purchased from Sigma-Aldrich (St. Louis, MO, USA). 0.5-μm bare 
silica particles were purchased from Superior Silica (Temple, AZ). Methyltrichlorosilane 
(C1) and Octadecyltrichlorosilane (C18) were from Gelest (Morrisville, PA). 
Phosphorylated histone H1 sample was extracted from MDA-MB-231 cells treated with 
nocodazole. 
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3.2.2 Capillary with Packed Silica Colloidal Crystals 
The capillary for separation was prepared as follows.[15] Briefly, 0.5-μm bare 
silica particles (Superior Silica, Temple, AZ) were calcined at 600 °C for 10 hours for 
three times and then annealed at 1050 °C for 3 hours. The annealed particles were 
rehydroxylated in 0.1 M nitric acid for 3 hours and then suspended in water to form the 
slurry with 30% wt. concentration. Empty capillary (Polymicro, Phoenix, AZ) was 
washed by 0.1 M NaOH for 1 hour and rinsed by distilled water for 10 min. The slurry 
was injected to the empty capillary by a syringe and then packed with a high-pressure 
pump under sonication. The packed capillaries were vertically placed until dry. For 
surface modification, the dry capillaries were put into a humidity chamber at 50% 
humidity for an hour, then transferred into 20 mL dry toluene with 2% C1 and 16% C18 
for 5 hours. These modified capillaries were washed by dry toluene to remove free silane, 
and put in 120 °C oven for 4 hours. A P-2000 laser tip puller (Sutter instruments, Novato, 
CA) was used to pull the end of capillaries. 
3.2.3 NanoLC-MS and LC-MS of Histone  
A separation of histones was performed using a Thermo Dionex Ultimate 3000 
nano-UHPLC coupled to a Thermo LTQ Velos mass spectrometer. A Supleco 
Discovery? C18 column (1 mm* 15 cm, 5 ?m, 300 Å) was purchased from Supelco (St. 
Louis, MO) and used for comparison. The experiments with the Discovery column were 
performed using a Thermo Accela UHPLC and the above-mentioned mass spectrometer. 
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Mobile phases A and B were water and acetonitrile, respectively. Two sets of 
modifiers were used: the first was 0.5% formic acid and 0.02% TFA and the second was 
0.1% DFA. The gradient started at 1% B for 2 min, then increased from 20% to 65% B in 
20 min and was maintained at 70% B for 1 min, and then re-equilibrated back at 1% B 
for 8 min to prepare for the next injection. Flow rate was varied from 30 nL/min to 150 
nL/min. For the phosphorylated H1 separation, the gradient was run from 30% B to 40% 
B over 20 min, and the flow rate was fixed at 100 nL/min. 
For nanoLC-MS, analytes were directly sprayed from the tip of capillary to the 
mass spectrometer. For LC-MS, analytes were ionized via ESI. Spray voltage was kept at 
2.4 kV for both nanoLC-MS and LC-MS. All spectra were obtained under positive ion 
mode over the mass range from 500 to 2000 m/z. The deconvolution of all mass spectra 
was performed with MagTran 1.0 software. 
3.2.4 LC Separation of Histones 
Histones for LC separation were from the same stock sample as was used in the 
nano-LC-MS experiments. An Agilent 300SB core-shell column was used for evaluating 
the acidic modifiers for the histone separations. These separations were performed on a 
Waters I-Class UPLC (Milford, MA) and detected by UV absorbance spectroscopy. 
Water and acetonitrile were used as mobiles phase A and B, respectively. Three sets of 
acid modifiers were used for comparison: 0.1% TFA, 0.5% FA and 0.02% TFA, and 0.1% 
DFA. Gradient was from 25 to 50% B in 60 min. Flow rate was kept at 0.067 mL/min in 
order to have the same average retention factor. Column temperature was 30 °C. 
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Wavelength of UV detection was 210 nm for the solvent with 0.1% TFA and 0.1% DFA, 
and 280 nm for the solvent with 0.5% FA and 0.02% TFA. 
3.3 Results and Discussion 
RPLC of proteins requires an acidic modifier to minimize peak tailing, and 
histones are especially sensitive to acid modifiers because their high abundances of 
lysines invite interactions with silanols. The modifier best for RPLC is trifluoroacetic 
acid (TFA), whereas the best modifier for efficient electrospray is 0.5% formic 
acid/0.02% TFA. For LCMS, the high surface activity of TFA leads to ineffective spray 
formation during ESI, resulting in inadequate sensitivity.[17] Formic acid give lower 
chromatographic resolution due to its high pKa.[18] A compromise is difluoroacetic acid 
(DFA), which has a lower pKa than formic acid and less surface activity than TFA.[19] 
To gauge how much chromatographic efficiency is at stake in selecting the modifier, 
RPLC with UV detection was used for the histone separation. The use of UV detection 
avoids issues in the electrospray process in assessing the chromatographic resolution. 
Figure 1 compares the chromatograms for the three different modifiers in the separation 
of the histones: A) 0.1% acid (TFA), B) 0.5% formic acid (FA) plus 0.02% TFA, and C) 
0.1% DFA. All three modifiers easily allow the H1 histones, which are peaks 1 and 2, to 
be separated. The TFA modifier allows close to baseline resolution of the core histones, 
which are peaks 3-7. The other modifiers give distinctly lower resolution and more peak 
tailing, as expected from their lower acidities. For FA+TFA, only three core histone 
peaks are resolved, instead of five. For DFA, four of the five core histone peaks are 
resolved, with the fifth peak appearing as a shoulder. DFA is thus a reasonable 
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compromise, as the results show that only half of the resolution is lost in going from TFA 
to DFA.  
The peaks in the chromatograms of Figure 1A were identified by collecting 
fractions from the chromatograph, exchanging the 0.1% TFA for 0.5% formic acid, and 
directly electrospraying into the mass spectrometer. The mass spectra and deconvoluted 
mass spectra for all seven peaks are provided in the supporting information. Table 1 
provides a summary of the assignments. Except for peak 4, the peaks are mixtures of 
histones with differing molecular weights, but these are similar enough to be attributed to 
post-translational modifications. Hence, peak 3, for example, is assigned to a mixture of 
post-translational modifications of the core histone H2B. The one exception is peak 7, 
whose molecular weight is ambiguous: it can either be H2A or H3. Some post-
translational modifications give separable species, e.g., peaks 5 and 6 are both from H2A. 
Subscripts are designated to facilitate referring to these in the discussions.  
The gradient for LC separation of the histones by the slip flow capillary was 
optimized by varying the gradient time for a fixed flow rate of 100 nL/min. This flow rate 
corresponds to a linear velocity of 0.7 mm/s, which is sufficiently slow for good 
efficiency in protein separations. For gradient elution, it is the ratio of the gradient time, 
tG, to the column dead time, t0, that is optimized to give an average retention factor, k*, 










Optimal gradients are expected to be those that have k* between 1 and 10. The gradient 
was for 25% to 50% acetonitrile, giving a gradient range, ??, of 25%. The parameter S is 
   32 
the slope of log(k) vs. ?, which depends on the protein. For lysozyme, which is also a 
strongly basic protein, S~25 (REF DOI 10.1016/S0021-9673(01)96400-3), which would 
estimate that gradient lengths of 10 to 85 min would give k* in the range of 1 to 10 for 
histones. Figure 2 shows the chromatograms for varying gradient time from 10 min to 60 
min for the slip flow capillary. The peak intensities change with gradient time, which is 
likely due to bias in the electrospray. Based on the widths of the largest peak in the 
chromatograms, gradients longer than 10 min give better resolution, which is consistent 
with the estimate. For the gradients of 20, 40 and 60 min, longer gradients give somewhat 
better resolution, but this is offset by the lower S/N. The 20 min gradient is the choice for 
overall optimal performance and speed.  
To reference the results with those of a commercial column, separations were also 
performed with a commercial microbore column, Supelco Discovery, which has been 
used for histone proteomics. [1] As with the slip-flow capillary, the Discovery column 
also has a C18 bonded phase. The particles are 5 μm in diameter and fully porous, with 
300 Å pore size. For gradient optimization, since the column is three-fold longer (15 cm), 
for the same linear flow rate as the slip flow column, the gradient time needs to be three-
fold longer. The inner diameter is ten-fold larger: 1 mm i.d., compared to 100 μm i.d. for 
the slip flow capillary, thus necessitating 100x more moles injected for comparison of 
equivalent conditions. The chromatogram for the case of equal tG/t0 and mobile phase 
velocity, and equivalent injected amount, is shown in Figure 3A. The chromatogram 
shows that fewer peaks are observed. This could be a consequence of the electrospray 
interface using a two-fold wider diameter orifice. It is important to note that the flow rate 
can be made higher for the commercial column because of its lower resistance to flow. 
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Higher flow rate gives a higher value of tG/t0, which is potentially advantageous since 
resolution improves with (tG/t0)1/2. There is an optimum because higher flow rate will 
eventually decrease the plate number due to the mass transport term. To explore the 
optimum, higher flow rates, 25 and 50 μL/min, were studied for the 60 min gradient, and 
the chromatograms are shown in Figure 3B and 3C. The values of tg/t0 for these 
chromatograms in comparison to the slip flow chromatograms as well as mobile phase 
velocities, are summarized in Table 2, showing that these two chromatograms have linear 
flow rates exceeding that of the slip flow column by 2x and 4x, and that tG/t0 exceeds that 
of the slip flow column also by 2X and 4x. The result shows that resolution is negligibly 
affected by either flow rate or the variations in tG/t0.  
Before exploring a detailed comparison, it is worth checking both the dependence 
of the chromatograms of loading and the reproducibility of the chromatograms. This is 
important since the number of peaks change when gradient conditions change. Figure 4 
shows chromatograms for varying amounts injected. Equivalent amounts are injected into 
the respective columns, as they have 100x different cross-sectional areas. For both 
columns, more peaks are evident as the injected amount is increased. Again, this is likely 
from the nonlinearity of the electrospray process. 
Figure 5 shows replicate chromatograms for the two types of columns. The time 
axes have small shifts for both chromatograms, perhaps from the imprecision of the flow 
controls of each of the two chromatographs. The intensities also vary, as expected in 
using electrospray. Nonetheless, the differences among the replicates for a given column 
are smaller than the differences between columns, allowing a comparison. The gradient 
optimization had shown that there are different peaks for different gradient conditions, 
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whereas Figure 5 shows that a given gradient exhibits a set number of peaks and relative 
peak heights. Both are sufficiently reproducible for comparisons to be made. 
In studying column efficiency, any effect of partial overlap of peaks on the 
apparent peak capacity can be decreased by comparing extracted ion chromatograms. 
Figure 6 shows a comparison of the extracted ion chromatograms for the slip flow 
column for a 20 min gradient with tG/t0 =17 and the commercial column for a 60 min 
gradient and tG/t0=16. The peaks labeled 3 and 4, were fit to Gaussian to determine the 
standard deviations, and these were used to calculate the local peak capacities for just the 
core histones.  , which are x and y for the slip flow and commercial column, and the 
range of retention times for the peaks from H2B2 to H2A3, the peak capacity is Z fold 
higher for the slip flow column. Further, Figure 6 shows that the width of the H4 peaks 
for the slip flow column is limited by the smoothing algorithm used to reduce 
electrospray noise, whereas this is not a limitation for the commercial column since it is 
broader. Specifically, the standard deviation of the H4 peak for the slip flow column is 
1.56 s while the standard deviation of the smoothing function is 1.13 s, thus giving a 50% 
increase in the peak width. Considering this broadening, the peak capacity for the slip 
flow column is actually Z1 fold higher than the commercial column. Regardless of 
whether the smoothing is taken into account, the slip flow column delivers higher 
resolution in addition to the three-fold faster separation time. 
3.4 Concluding Remarks 
Separation efficiency was studied for histones using a slip-flow capillary column 
with sub-0.5 μm nonporous silica particles for LCMS. The slip flow column gives both 
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2x higher peak capacity and 3x higher speed compared to columns that are three-fold 
longer. One such column has fully porous 5 μm particles and the other has 3.6 μm core-
shell particles. In all cases, more peaks were observed as concentration increased 
presumably due to the nonlinearity of the electrospray process. The higher speed is a 
consequence of the column being shorter and the higher peak capacity is attributed to the 
number of plates being higher despite the shorter length. DFA was found to give better 
resolution than 0.5% formic acid with 0.02% TFA. Slow gradients can be used to further 
resolve the histones if analysis time is not considered as a limitation. This separation 
method can be applied on top-down proteomics of histones by coupling to higher 
resolution mass spectrometers to allow more detailed characterization for PTMs of 
histones in future. 
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CHAPTER 4: NANO-LC-MS OF PROTEIN DIGESTS USING NONPOROUS 
SUBMICRON PARTICLES 
4.1 Introduction 
LC-MS of peptides has been widely used as an assay for protein identification in 
both proteomic research and pharmaceutical industry.[1, 2] The difficulty of intact 
protein characterization is reduced by using enzyme digestion and LC-MS or LC/MS/MS 
on the digested protein sample. By comparing the detected mass spectra with the 
signature peptides of proteins in the database, intact proteins can be identified. However, 
proteins sample might contain more than 1000 peptides after tryptic digestion.[3] The 
large number of peptides results in co-elution, which taxes the analysis by the mass 
spectrometer. More efficient separation of peptides would increase the number of 
proteins identified.  
Peak capacity is one of the criteria to evaluate the separation of peptides.[4, 5] It 
represents the theoretical number of peaks that can be separated in a certain analysis time. 
Higher peak capacity of peptides means more proteins can be identified.[6] Various 
strategies, such as increased separation length and analysis time, have been used to 
increase peak capacity for peptides separation.[7-12] With a 200 cm long column, Shen 
et al. achieved a peak capacity of 1000-1500 using a 2000 min gradient.[13] Long 
columns with monolithic structure or core-shell particles were also developed to increase 
the peak capacity in peptides separation. [14-19] De Vos used a 2.6 um core-shell column 
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and obtained peak capacity of 1360 with 480 min gradient and 1200 bar operating 
pressure.[20] All these methods provided high peak capacity for peptides separation. 
However, the long analysis time used in these methods to achieve high peak capacity 
makes it less desirable for routine use. High efficiency and speed of peptides separation is 
desired.  
In the previous chapter, slip flow chromatography had shown faster and more 
efficient separation of histones and other intact proteins due to the smaller, orderly 
packed particles and the horizontally polymerized bonded phase.[21-23] The current 
chapter discusses the application of slip flow chromatography on peptides separation. In 
this work, 500 nm silica particles were packed into a 150 μm i.d. capillary and modified 
to generate a C18 bonded stationary phase, with a pulled tip to directly couple to the mass 
spectrometer. Bovine serum albumin (BSA) tryptic digest and HeLa cell lysate tryptic 
digest were used as samples to test the ability of slip flow column for complexed sample 
separation.  
4.2 Material and Methods 
4.2.1 Materials 
0.5-μm nonporous silica particles were purchased from Superior Silica (Temple, 
AZ). HPLC grade water, acetonitrile, formic acid and trifluoroacetic acid were purchased 
from Sigma-Aldrich (St. Louis, MO). Trypsin digested bovine serum albumin was from 
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Waters Corporation (Milford, MA). HeLa cell digest was purchased from Life 
technologies. 
4.2.2 Preparation of Capillaries 
The capillary was prepared as described previously.[22] Briefly, 0.5-μm 
nonporous silica particles were calcined at 600 °C three time and annealed at 1050 °C 
once, followed by rehydroxylation with 0.1 M nitric acid at 250 °C. The rehydroxylated 
particles were suspended in water to form a 30% wt. slurry. After overnight sonication, 
the slurry was injected into a 150 μm i.d. fused silica capillary (Polymicro, Phoenix, AZ) 
which had been rinsed by 0.1 M NaOH and water previously. With a high-pressure 
pump, the capillary was packed with ethanol under sonication. After dry, a match was 
used to burn the polyamide coating of capillary off near the end of packed bed. A 
monolayer of C18 bonded phase was put onto the silica by dipping capillary in 20 mL 
toluene with 2% Methyltrichlorosilane and 8% Octadecyltrichlorosilane (Gelest, 
Morrisville, PA) for 5 hours. The modified capillary was rinsed with toluene and placed 
in 120 °C oven until dry. The end of capillary was pulled by a P-2000 laser tip-puller 
(Sutter instruments, Novato, CA) in order to couple to mass spectrometer. 
4.2.3 Measurement of Diffusion Coefficient in Mobile Phase 
A 1.5-kDa synthesized peptide was used in the experiment. The peptide for 
measurement was purchase from AnaSpec (Fremont, CA). The measurement was 
performed on a Thermo Dionex Ultimate 3000 nanoLC and detected by a fluorescence 
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microscopy. The procedures of measurement were as follows. At 100 nL/min mobile 
phase flow rate, the peptide was injected to the capillary in 1% acetonitrile and eluted at 
50% acetonitrile. The length from the head of capillary column to detection window was 
4 cm. When the peptide peak appeared on the middle of detection window, the flow was 
stopped for varying amounts of time to allow diffusion of peptides. Incubation time and 
widths of peptide peak were recorded for linear fitting and calculation. After 100 s, the 
flow was started again to elute the peptide peak from capillary. 
4.2.4 NanoLC-MS of Peptide Separation 
Peptides were separated with Thermo Dionex Ultimate 3000 nano-UHPLC and 
ionized via electrospray ionization before entering a Thermo LTQ Velos mass 
spectrometer. HPLC grade water and acetonitrile with 0.5% formic acid and 0.02% TFA 
were used as mobile phase A and B, respectively. The gradient conditions for both BSA 
digest and HeLa cell digest were as below. Acetonitrile in mobile phase was held at 1% 
for 2 min, and then increased from 1% to 40% in 17 min for fast gradient and 34 min for 
slow gradient, followed by increasing to 70% in 2 min and decreasing to 1% in 1 min. 
Then the capillary was equilibrated at 1% acetonitrile for 8 min. The flow rate was kept 
at 200 nL/min. The electrospray ionization of peptides was performed at 2.5 kV spray 
voltage under positive ion mode. The mass range of detection was set as 400-2000 m/z. 
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4.2.5 Measurement of Diffusion Coefficient on Stationary Phase 
The peptide from AnaSpec (Fremont, CA) was used for measurement. The 
polyamide coating at end of a C18 capillary was burned off to allow fluorescence 
detection. After equilibrating with 1% acetonitrile, the capillary was dipped into the 
peptide sample for 10 seconds for diffusion injection. The injection band was imaged 
every 2 min to record peak widths. Then the solvent composition was changed to 50% 
mobile phase B to elute the peptides. The measurement was also performed at 5%, 10% 
and 15% mobile phase B to compare the diffusion on stationary phase under different 
solvent conditions. 
4.3 Results and Discussion 
For chromatographic separation, the plate height H, is usually described by van 
Deemter equation as a function of mobile phase velocity (v): 
? ? ? ? ??? ? ?
??
?? ? 
In this equation, A term is eddy diffusion that depends on the particle size and 
packing quality of column. The second term, longitudinal diffusion, is determined by the 
mobile phase velocity and obstructed diffusion coefficient of analyte (?D) in the mobile 
phase. The last term is resistance to mass transfer, while dP is particle size and w is a 
constant. Our group has demonstrated that the A term is negligible resulting from small 
particle size and homogeneous packing of stationary phase. [24] However, the 
broadening from longitudinal diffusion still remains unknown for peptide separation.  
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To calculate how much the longitudinal diffusion term contributes to total plate 
height, the obstructed diffusion coefficient of peptides in mobile phase was measured. 
Based on the peak widths of peptides and incubation time after stopping the mobile phase 
flow, the diffusion coefficient can be calculated by the equation 
??? ? ??? 
As shown in figure 4.1 (A), the change of peak width variance (??2) linearly 
increased with the incubation time (t). As a result of the linear fitting, the obstructed 
diffusion coefficient of peptides was found to be 6.19?10-7 cm2/s. The longitudinal 
diffusion contribution to plate height, HB, was calculated to be 347 52 nm based on 
above equation.  
The plate height can be expressed as a function of peak variance (?2) and 




In a separation length of 3.5 cm, the plate height was 277 74 nm for this peptide 
peak, given the initial peak width was 98 μm. Therefore, the total plate height was almost 
entirely contributed by the longitudinal diffusion, which means that the separation was 
limited by peptide diffusion. To minimize diffusion, the mobile phase flow rate for the 
peptide separation was kept at 200 nL/min, which is the maximum flow rate due to the 
pressure limit of LC instrument. 
TFA is the most widely used mobile phase modifier in chromatography due to its 
excellent ion-pairing ability. However, with the commonly used concentration (0.1%), 
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the high surface tension of TFA suppresses the MS signal. Formic acid is commonly used 
to replace TFA in online LC-MS applications. However, the commonly used 
concentration (0.1%) of formic acid can cause peak tailing and poor chromatographic 
resolution. To study the influence of modifier concentration on peptides separation, 
mobile phases with different percentage of formic acid and TFA were tested for peptides 
separation to achieve the highest resolution.  
Figure 4.2 showed the separation of BSA tryptic digests by using 0.1% formic 
acid, 0.5% formic acid, 0.5% formic acid/0.02% TFA, and 0.5% formic acid/0.04% TFA. 
Generally speaking, the resolution of peptides was increased as the acid concentration 
was increased, especially for the two peaks labeled in blue rectangle. However, the 
addition of TFA in mobile phase decreased the S/N (signal to noise ratio) of the 
chromatogram. Intensity of the most abundant peak was dropped from 6.0?106 to 1.6?106 
and 1.2?106 while adding 0.02% and 0.05% TFA in 0.5% formic acid. As a compromise, 
0.5% formic acid and 0.02% TFA was used as acid modifier for the following 
experiments.  
With the optimized mobile phase, slip flow capillary was applied to the separation 
of a BSA tryptic digest for the calculation of peak capacity. Peak capacity represents the 
theoretical number of peaks that can be separated in a certain long gradient. Here we use 




In this equation, tf and ti are the retention time for the last and first eluted peaks, 
so tf - ti is the length of eluting window of peptides. Term w is the base width of the 
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narrowest baseline resolved peak. In figure 4.3 (A), with a 17 min gradient, half widths of 
the peaks were as small as 2 s. The separation and Gaussian fitting of the peaks at 
expanded scales showed the narrowest peak was only 0.9 s for half width, resulting in a 
peak capacity of 380. The peak capacity per min was calculated to be 33, which was 
higher compared to other works using similar gradient time. Similarly, with a 34 min 
gradient, the peak capacity was calculated to be 500. This high peak capacity 
demonstrated the efficient and fast separation of peptides by slip flow capillaries.  
In order to pursue higher peak capacity, a longer gradient is necessary. One factor 
needs to be considered while using a long gradient is the possible diffusion of peptides on 
the stationary phase. The measurement of diffusion coefficient of peptides on stationary 
phase was described in 4.2.5. According to the results (figure 4.4), the diffusion 
coefficient on stationary phase was found to be 9?10-11 cm2/s, which is three orders of 
magnitude smaller than in mobile phase. This gives a negligible percentage of peak 
broadening as long as tG exceeds t0 by less than a factor of 1,000. For a 60 min gradient, 
the width caused by broadening on stationary phase for the last eluted peak would be 
only 8 μm, which is about 1/40 of the overall peak width. 
The slow diffusion on stationary phase enables the separation by longer gradients 
for peptide separations. A more complex sample, the tryptic digest of a HeLa cell lysate, 
was used for separation with a longer gradient. For the separation with 17 min gradient, 
the peak capacity was 380, which was similar to previous BSA tryptic digests separation. 
With a four times longer gradient, more peaks were found in the 68 min separation. The 
narrowest peak was only 0.96 s for half width, which leads to a peak capacity of 1400. 
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This high peak capacity is partly attributed to the new peaks being baseline resolved by 
the use of the long gradient. 
4.4 Concluding Remarks 
In this chapter, the application of slip flow capillary on peptide separations was 
discussed. The measurement of the obstructed diffusion coefficient of a peptide in mobile 
phase showed that the separation was limited by peptide diffusion. A peak capacity of 
380 was obtained in a 17 min gradient for protein tryptic digests. For a 68 min gradient, 
the peak capacity was increased to 1400, which is sufficient for routine separation of 
peptide samples. The further increase of peak capacity would require either a longer 
gradient or a faster flow rate since the diffusion of peptides in mobile phase can be 
reduced via the increase of linear mobile phase velocity. One can expect that the peak 
capacity will be further enhanced in the future with an instrument that has higher pressure 
limit. 
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CHAPTER 5: APPLICATIONS OF SLIP FLOW CHROMATOGRAPHY ON INTACT 
PROTEINS 
5.1 Ubiquitin Characterization 
This project is an ongoing collaboration with Prof. Chittaranjan Das.
Ubiquitin plays an important role in many biological processes.[1-3] Proteins can 
be linked to ubiquitin from multiple sites of lysine or arginine groups. By binding to 
substrate proteins, ubiquitin can regulate various cellular responses, such as protein 
degradation[4] and DNA repair[5-7]. This binding process is called ubiquitination. 
Common ubiquitination includes three steps: activation, conjugation and ligation, with 
the corresponding enzymes as E1, E2 and E3.[8, 9] Recently, it was reported that one 
enzyme (SdeA) from infectious bacterium, legionella pneumophioa can catalyze the 
ligation of ubiquitin and protein substrate without ATP or enzymes like E1 and E2.[10, 
11, 19] The linker and pathway between ubiquitin and these proteins still remain 
unknown. One hypothesis is a two-step pathway from ubiquitin to ubiquitin-protein 
complex. First, the ubiquitin goes through ADP-ribosylation at Arg-42 to form an 
intermediate ubiquitin-ADP-Ribose (Ub-ADPR) under enzyme catalysis. The second step 
is the reaction between Ub-ADPR and a nucleophilic acceptor on a side chain of the 
substrate protein. To confirm this pathway, LC-MS of the intact protein would reveal the 
mass of the linker. A mass difference of 954 Da between Ubiquitin and ubiquitin-ADP-
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Ribose would be a confirmation for the first step of this pathway. The purpose of this 
work is to determine the masses of the intact ubiquitin, the intermediate ubiquitin-ADP-
Ribose, and the ubiquitin-linker-protein complex by using LC-MS with slip flow 
chromatography. [12, 13] 
Using a 5-cm C18 slip flow capillary, two peaks for an ubiquitin sample was 
resolved in a 10 min gradient (figure 5.1). The first peak (Ub-1) has a mass of 8587 Da, 
and the second peak (Ub-2) has a mass of 8571 Da. By comparing with the calculation 
results, Ub-1 was attributed to either a colonial fragment or addition of a water molecule. 
Using the same separation method for the ubiquitin-linker complex (Ub-ADPR), the 
results showed two peaks in the chromatogram (Figure 5.2). The prolonged retention time 
of Ub-ADPR indicates increased hydrophobicity upon adding the linker to ubiquitin. In 
each chromatographic peak, two species were found based on the mass spectra and 
deconvoluted mass spectra. The mass of 9525 Da confirmed the linker mass to be 
Ubiquitin-ADPR, which is consistent with the hypothetic mass of ubiquitin-ADPR. 
Similarly, the mass of 9542 could be due to water molecular addition to Ubiquitin-
ADPR. Rab 33 is selected to be the substrate protein as a proof of concept. Next step of 
experiment is to characterize the Rab33 and Rab33-linker-ubiquitin complex. By 
subtracting the mass of Ubiquitin-ADPR and Rab33 from Rab33-linker-ubiquitin 
complex, the molecular weight of the linker can be calculated. 
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5.2 Separation of RRM2 Monomer and Dimer 
This project was collaborated with Prof. Nikolai Skrynnikov. 
RRM protein is a RNA binding platform that plays important role in regulating 
post-translational gene expression.[14, 15] RRM2, or RNA recognition motif 2, is an 8.7 
kDa polypeptide that belongs to the RRM protein family.[16-18] NMR is a common 
method to study RRM proteins. Previous study showed peak distortion and disappearance 
of NMR spectrum for hydrogen peroxide treated RRM2. One possibility is the 
dimerization of RRM2. Under the presence of hydrogen peroxide, the one cysteine on the 
surface of RRM2 is possible to react with the cysteine on another RRM2 protein and 
form a dimer. Therefore, the NMR spectrum would be different compared to the RRM2 
monomer. To test this hypothesis, RPLC-MS is applied to the separation of both 
controlled and hydrogen peroxide treated sample. 
Using nano-LC-MS, three sets of samples were analyzed, including the controlled 
sample, 1-hour H2O2 treated RRM2 sample and 24-hour H2O2 treated RRM2 sample. 
With a C18 slip flow capillary, more than 10 monomer and dimer peaks were separated 
for all samples. In figure 5.3, the RRM2 sample without any treatment showed one most 
abundant monomer peak with the mass of 8705 Da. There were also six other monomer 
peaks and one dimer peak (peak 8). The intensity of the dimer peak was quite low 
compared to the monomers. Two other peaks with the mass of 11.7 kDa (peak 9 and 10) 
were eluted after the dimer peak, which could be the fragments of the dimer. Similarly, 
the RRM2 sample with 1 hour H2O2 treatment showed 6 monomer peaks, 1 dimer peak 
and 2 fragment peaks. However, only small amount of dimer was found in H2O2 treated 
sample, while major fraction still remained as monomer (figure 5.4). To further study 
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whether H2O2 treatment can cause dimerization of RRM2, the third set of sample, RRM2 
with 24-hour H2O2 treatment were tested. In figure 5.5, both the number and intensity of 
dimer peaks were increased compared to previous results, while the relative intensity of 
monomer peaks was decreased. This supports the hypothesis that dimerization of RRM2 
is caused by H2O2 treatment. However, the RRM2 used in NMR study was treated by 
H2O2 for only one hour, which only contained a small amount of dimer. To conclude, 
although H2O2 treatment can cause dimerization of RRM2, it was not the main reason of 
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CHAPTER 6: CONCLUSION AND FUTURE DIRECTION 
6.1 Conclusion 
This dissertation discussed the development of both technology and methods of 
protein separation using slip flow chromatography. Slip flow chromatography is based on 
the stationary phase of nonporous submicrometer silica particles. The small particle size 
reduces eddy diffusion and resistance to mass transfer while nonporous particles 
eliminate the intra-particle diffusion. Slip flow effect reduces the back pressure of using 
small particles and enables the usage of commercial UHPLC instruments.  
With slip flow chromatography, the capillary with C18 bonded phase was 
successfully applied on LC-MS of intact proteins. One application of slip flow capillary 
is the separation of histones. Histones are basic proteins to form nucleosomes. The PTMs 
on histones participate in regulating biological processes and correlate to different stages 
of multiple cancers. The separation of histones can promote the characterization of 
histone PTMs with top-down proteomics, and therefore help understanding the 
mechanisms of histone PTMs for diagnosis and treatment of diseases. With a 5 cm C18 
slip flow capillary, resolution of histones was greatly enhanced compared to commercial 
columns. The analysis time of using slip flow capillary was three times shorter while the 
peak capacity was twice higher than commercial column at the same k* condition. High 
efficiency was also achieved when applying slip flow capillary on peptides separation. 
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With a 17 min gradient, a peak capacity of 380 was reached for the mixture of BSA 
peptides. By changing the silane reagents to form the horizontal polymer surfaces, 
different selectivity was developed for the separation of other protein samples, such as 
monoclonal antibodies. Using a column with TDP bonded phase, comparable resolution 
was obtained for IgG1 separation compared to commercial core-shell column. Other 
bonded phases, such as C4, can be also used for intact and reduced antibody separation. 
This dissertation also discussed the application of slip flow capillary on other intact 
proteins, such as ubiquitin and RRM2. These LC-MS results demonstrate the high 
efficiency of intact protein separation by using slip flow capillary. 
6.2 Future Direction 
6.2.1 Histones Separation 
Slip flow capillary provides high resolution and sensitivity of histones in short 
analysis time. However, the presence of the large number of variants in each histones 
family and PTMs on different histones makes the analysis of histone PTMs very 
complicated.[1-4] In order to obtain detailed PTM information for each individual 
histone, resolution of histones separation needs to be further enhanced. 
One way to achieve higher resolution is to decrease the gradient slope[5], and also 
the flow rate at the same time in order to keep the k* constant.[6] The resolution among 
the peaks might be different because the C term is different for each type of histones. 
Overall, the resolution will increase as the gradient time increases.[7] To illustrate, a 
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separation of using slow gradient and slip flow capillary was performed on a collected H4 
fraction. The sample was received from Prof. Neil Kelleher’s research group and used 
after dilution with water. Figure 6.1 showed the preliminary data for histones H4 
separation. With slip flow capillary, four peaks were resolved by a 20 min gradient from 
40 to 50% acetonitrile while each peak contained several partially resolved shoulders. 
The second and third peaks were identified as H4 histones according to their mass 
spectra. Compare to the one single peak in the separation for fraction collection (left 
chromatogram in figure 8.1), resolution was enhanced by the usage of slip flow capillary 
and slow gradient.  
Another method is to use longer columns. As we know, resolution increases with 
the square root of separation length.[8] With a longer column, the partially resolved 
histones will be separated better. In addition, the increased width of histones peaks can 
provide longer analysis time for the detection of mass spectrometer. Despite the 
advantages, one concern of using a longer capillary is the back pressure. At 200 nL/min 
flow rate, the back pressure is about 650 bar for a 5 cm slip flow capillary with 0.1 mm 
internal diameter. If the length of capillary is increased by a factor of 2, the back pressure 
will be 1300 bar at the same flow rate, which is way beyond the pressure limit of current 
UHPLC instruments. This problem can be solved by using slower flow rate or capillary 
with larger internal diameter. If decreasing the flow rate with the same factor of 
increasing the length of column, the back pressure will remain the same. The prolonged 
gradient delay can be avoided by adding flow splitter before the head of column. 
Therefore, the resolution will be enhanced while the back pressure is still in the range of 
common UHPLC instruments. 
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6.2.2 Reducing Noise of Nano-ESI 
Slip flow capillary provides highly efficient separation for intact proteins.[9-11] 
Horizontal polymerization not only provides a high quality bonded phase for protein 
separation, but also stabilizes the surface and structure of the capillary.[12] Therefore, the 
lifetime for slip flow capillary is fairly long. The resolution of proteins remains almost 
the same after more than one year of usage and hundreds of injections. However, for LC-
MS with slip flow capillary, the spectrum became noisy after the capillary was heavily 
used for a few weeks. One hypothesis is the buildup of lump pieces in the small pores 
created by melted particles in the tip. To fabricate one slip flow capillary, the end of 
capillary was pulled by a laser tip puller after the silica particles were packed into the 
fused silica capillary and modified with silane reagents. During the tip pulling process, 
the temperature of laser beam is as high as 1200 °C, which can melt both quartz and 
silica particles. The melted silica particles glue together and make the flow channels 
smaller. In addition, the bonded phase is also burned off in this process and thus making 
the surface more sticky. With this method, the tip can be easily blocked by the lump 
pieces eluted from the column, such as proteins, bacteria and dusts.  
Two methods can be used to avoid the melt of particles. One is to change the 
fabricating procedure and pack particles after pulling tip of capillary. To move the tip-
pulling step to the first, the following procedures have to be operated carefully to not 
break the tip. Figure 6.2 showed the comparison of capillaries fabricated with this method 
and the conventional slip flow capillary. The noise of electrospray was greatly reduced 
compared to the conventional slip flow capillary. Next step is to optimize the packing and 
modification of silica particles to improve the resolution of protein separation. 
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The second method is to use an emitter after the column. Figure 6.3 showed the 
comparison of the diagrams for capillaries with integrated tip and extra emitter. The 
addition of an emitter can increase the reproducibility of electrospray since the emitter 
can be replaced once it is blocked. However, the disadvantage of this method is the post 
column broadening created by the emitter. The commercially available emitters have 
internal diameter of as small as 10 μm. The void volume brought by a 2 cm emitter is 1.6 
nL, which is negligible. The broadening is then mainly from the transition of analytes 
traveling from a large internal diameter to a channel of small internal diameter. Therefore, 
a balance between the sacrifice of resolution and the enhancement of S/N needs to be 
found with this method. 
6.2.3 Development of New Stationary Phases 
Current surfaces of slip flow capillary for proteins separation include C4, C18 and 
TDP.[13] With these bonded phases, high efficiency of separation has been achieved for 
histones, peptides, intact and reduced antibodies. In order to improve the resolution of 
more analytes, other bonded phases need to be developed for slip flow capillary. Two 
possible methods are listed as below. 
The first method is to vary the carbon chain length. The influence of carbon chain 
length of silane reagents on proteins separation has been discussed.[14] It is possible to 
use silane reagents with longer carbon chains for the formation of bonded phase to 
improve the resolution of small analytes, such as peptides.[15] Also, C8 bonded phase 
was proved to be effective on histones and intact antibody separation.[16] One can expect 
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the slip flow capillary with C8 bonded phase can further improve the resolution of intact 
antibodies. 
Another possible direction is to generate a polyacrylamide brush layer on the 
BC/C1 surface of slip flow capillary for hydrophilic interaction chromatography. Column 
with polyacrylamide brush layer has achieved high resolution on Ribonuclease B and 
prostate specific antigen (PSA) separation.[17] The methodology of fabricating HILIC 
capillary with polyacrylamide surface was also developed before. Figure 6.4 showed the 
separation of Ribonuclease B by using HILIC capillary. Five isomers of ribonuclease B 
were resolved in a 30 min gradient. Combining with the easy integration to MS, the 
HILIC capillary can be used for the separation of more glycoproteins, such as antibody 
with N-glycosylation, or as a second dimension for the separation of complex mixtures to 
provide higher resolution and sensitivity. 
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For top-down proteomics, more efficient separations are needed for intact histones and 
their variants, including both linker and core histones. A 4-cm capillary packed with 
nonporous 470 nm silica particles was found to exhibit two-fold higher peak capacity for 
the separation of histones, compared with a 15-cm long commercial microLC column 
packed with 5 μm particles. Each used the same gradient of water/acetonitrile with 
difluoroacetic acid, and a C18 bonded phase. In addition, the signal-to-background ratio 
was more than two-fold higher for the capillary packed with submicrometer particles. 
This enabled peaks as low in abundance as 0.1% of the highest peak to be characterized 
   88 
by the mass spectrometer. The peak at 0.1% abundance corresponds to <500 amole (<10 
pg) of histone. Histone phosphorylation and other PTMs were identifiable even for the 
peaks of 0.1% in abundance, which is not possible for the commercial column. This 
allows for more subtle differences in diseased vs. healthy tissue to be discerned. 
INTRODUCTION 
Histones, including core histones (H2A, H2B, H3 and H4) and linker histones (H1), are 
basic chromosomal proteins that are involved in many physiological processes mostly 
through its post-translational modifications (PTMs).[1, 2] These PTMs, including 
phosphorylation, methylation, acetylation and ubiquitination,[3] can work individually or 
covalently to generate a ‘histone code’ that participates in the regulation of various 
cellular responses such as gene transcription and DNA repair.[1, 4, 5] Recent studies 
showed that the levels of histone PTMs are correlated to different stages of cancer.[6, 7] 
Therefore, understanding the function and mechanism of histones PTMs could benefit 
early diagnosis and treatment for various diseases. However, the analysis of PTMs in 
intact histones is difficult due to the large number of histone variants that may differ by 
only a few amino acid sequences.[2] On the other hand, conventional methods such as 
bottom-up proteomics risk losing PTMs information in the digestion processes.[8, 9] 
Therefore, characterization of intact histones is essential to fully understand and utilize 
histone PTMs as biomarkers for cancer diagnosis. 
Top-down proteomics has been proven to be an effective method for intact histones 
analysis because one must characterize multiple PTMs on the same protein.[9, 10] 
Kelleher and coworkers discovered 42 forms of H4 histones through the use of an offline 
RPLC-HILIC-FTMS.[11] With RPLC-MS, Su et al. completed the profiling of whole 
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histones and the PTMs including methylation and acetylation.[12] Contrepois et al. 
developed a method to characterize core histone variants and PTMs in 20 min via RPLC-
LTQ-Orbitrap.[13] However, owing to the poor chromatographic resolution of histone 
variants, these LC-MS methods suffer from laborious fractionation and long analysis time. 
Methods that use a faster gradient to reduce analysis tine would otherwise sacrifice the 
resolution and increase the complexity of mass spectra. Hence, higher efficiency of 
separations are desired for intact histones in top-down proteomics. 
With uniformly packed 0.5 μm silica nanoparticles, slip flow chromatography has 
significantly advanced the efficiency of intact protein separations via reduced particle 
size and slip flow enhancement.[14-16] The purpose of this work is to test whether this 
advance benefits top-down proteomics analysis of intact histones. 
MATERIALS AND METHODS 
Materials 
HPLC grade water, acetonitrile, formic acid, TFA, DFA and histones from bovine calf 
thymus were purchased from Sigma-Aldrich (St. Louis, MO, USA). 0.5-μm bare silica 
particles were purchased from Superior Silica (Temple, AZ). Methyltrichlorosilane (C1) 
and Octadecyltrichlorosilane (C18) were from Gelest (Morrisville, PA). Phosphorylated 
histone H1 sample was extracted as previously reported. 
Capillary with packed silica colloidal crystals 
The capillary for separation was prepared as follows.[15] Briefly, 0.5-μm bare silica 
particles (Superior Silica, Temple, AZ) were calcined at 600 °C for 10 hours for three 
times and then annealed at 1050 °C for 5 hours. The annealed particles were rehydrolized 
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by 0.1 M nitric acid for 3 hours and then suspended in water to form the slurry with 30% 
wt. concentration. Empty capillary (Polymicro, Phoenix, AZ) was washed by 0.1 M 
NaOH for 1 hour and rinsed by distilled water for 10 min. The slurry was injected to the 
empty capillary by a syringe and then packed with a high-pressure pump under sonication. 
The packed capillaries were vertically placed until dry. For surface modification, the dry 
capillaries were put into a humidify chamber under 50% humidity for an hour, then 
transferred into 20 mL dry toluene with 2% C1 and 16% C18 for 5 hours. These modified 
capillaries were washed by dry toluene to remove free silane, and put in 120 °C oven for 
4 hours. A P-2000 laser tip puller (Shutter instruments, Novato, CA) was used to pull the 
end of capillaries.  
NanoLC-MS and LC-MS of histone separation 
Separation of histones was performed on a Thermo Dionex Ultimate 3000 nano-UHPLC 
coupled to a Thermo LTQ Velos mass spectrometer. A discovery C18 column (1 mm* 15 
cm, 5 um, 300 A) was purchased from Supelco (St. Louis, MO) and used for comparison. 
The experiments with discovery column were performed on a Thermo Accela UHPLC. 
Mobile phase A and B were water and acetonitrile, respectively. Two sets of modifiers 
were used: the first was 0.5% formic acid and 0.02% TFA and the second was 0.1% DFA. 
Gradient started at 1% B for 2 min, then increased from 20% to 65% B in 20 min and 
maintained at 70% B for 1 min and equilibrate at 1% B for 8 min. Flow rate was set from 
30 nL/min to 150 nL/min. For phosphorylated H1 separation, gradient started from 30% 
B to 40% B within 20 min, and the flow rate was 100 nL/min. 
For nanoLC-MS, analytes were directly sprayed from the tip of capillary to the mass 
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spectrometer. For LC-MS, analytes were ionized via ESI. Spray voltage was kept at 2.4 
kV for both nanoLC-MS and LC-MS. All spectra were obtained under positive ion mode 
over the mass range from 500 to 2000 m/z. The deconvolution of all mass spectra was 
performed with MagTran 1.0 software. 
RESULTS AND DISCUSSION 
Influence of acidic modifier on chromatograms with UV detection 
RPLC of proteins requires an acidic modifier to minimize peak tailing, and histones are 
especially sensitive to acid modifiers because their high abundances of lysines invite 
interactions with silanols. The modifier best for RPLC is trifluoroacetic acid (TFA), 
whereas the best modifier for efficient electrospray is 0.5% formic acid/0.02% TFA. For 
LCMS, the high surface activity of TFA leads to ineffective spray formation during ESI, 
resulting in inadequate sensitivity.[17] Formic acid give lower chromatographic 
resolution due to its high pKa.[18] A compromise is difluoroacetic acid (DFA), which 
has a lower pKa than formic acid and less surface activity than TFA.[19] To gauge how 
much chromatographic efficiency is at stake in selecting the modifier, RPLC with UV 
detection was used for the histone separation. The use of UV detection avoids issues in 
the electrospray process in assessing the chromatographic resolution. Figure 1 compares 
the chromatograms for the three different modifiers in the separation of the histones: (A) 
0.1% acid (TFA), (B) 0.5% formic acid (FA) plus 0.02% TFA, and (C) 0.1% DFA. All 
three modifiers easily allow the H1 histones, which are peaks 1 and 2, to be separated. 
The TFA modifier allows close to baseline resolution of the core histones, which are 
peaks 3-7. The other modifiers give distinctly lower resolution and more peak tailing, as 
expected from their lower acidities. For FA+TFA, only three core histone peaks are 
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resolved, instead of five. For DFA, four of the five core histone peaks are resolved, with 
the fifth peak appearing as a shoulder. DFA is thus a reasonable compromise, as the 
results show that only half of the resolution is lost in going from TFA to DFA.  
The peaks in the chromatograms of Figure 1A were identified by collecting fractions 
from the chromatograph, exchanging the 0.1% TFA for 0.5% formic acid, and directly 
electrospraying into the mass spectrometer. The mass spectra and deconvoluted mass 
spectra for all seven peaks are provided in the supporting information. Table 1 provides a 
summary of the assignments. Except for peak 4, the peaks are mixtures of histones with 
differing molecular weights, but these are similar enough to be attributed to post-
translational modifications. Hence, peak 3, for example, is assigned to a mixture of post-
translational modifications of the core histone H2B. The one exception is peak 7, whose 
molecular weight is ambiguous: it can either be H2A or H3. Some post-translational 
modifications give separable species, e.g., peaks 5 and 6 are both from H2A. Subscripts 
are designated to facilitate referring to these in the discussions.  
Gradient optimizations 
The gradient for LC separation of the histones by the slip flow capillary was optimized 
by varying the gradient time for a fixed flow rate of 100 nL/min. This flow rate 
corresponds to a linear velocity of 0.7 mm/s, which is sufficiently slow for good 
efficiency in protein separations. For gradient elution, it is the ratio of the gradient time, 
tG, to the column dead time, t0, that is optimized to give an average retention factor, k*, 
for the analyte as it travels through the column.  
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Optimal gradients are expected to be those that have k* between 1 and 10. The gradient 
was for 25% to 50% acetonitrile, giving a gradient range, Df, of 25%. The parameter S is 
the slope of log(k) vs. f, which depends on the protein. For lysozyme, which is also a 
strongly basic protein, S~25, which would estimate that gradient lengths of 10 to 85 min 
would give k* in the range of 1 to 10 for histones. Figure 2 shows the chromatograms for 
varying gradient time from 10 min to 60 min for the slip flow capillary. The peak 
intensities change with gradient time, which is likely due to bias in the electrospray. 
Based on the widths of the largest peak in the chromatograms, gradients longer than 10 
min give better resolution, which is consistent with the estimate. For the gradients of 20, 
40 and 60 min, longer gradients give somewhat better resolution, but this is offset by the 
lower S/N. The 20 min gradient is the choice for overall optimal performance and speed.  
To reference the results with those of a commercial column, separations were also 
performed with a commercial microbore column, Supelco Discovery, which has been 
used for histone proteomics. [12] As with the slip-flow capillary, the Discovery column 
also has a C18 bonded phase. The particles are 5 μm in diameter and fully porous, with 
300 Å pore size. For gradient optimization, since the column is three-fold longer (15 cm), 
for the same linear flow rate as the slip flow column, the gradient time needs to be three-
fold longer. The inner diameter is ten-fold larger: 1 mm i.d., compared to 100 μm i.d. for 
the slip flow capillary, thus necessitating 100x more moles injected for comparison of 
equivalent conditions. The chromatogram for the case of equal tG/t0 and mobile phase 
velocity, and equivalent injected amount, is shown in Figure 3A. The chromatogram 
shows that fewer peaks are observed. This could be a consequence of the electrospray 
interface using a two-fold wider diameter orifice. It is important to note that the flow rate 
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can be made higher for the commercial column because of its lower resistance to flow. 
Higher flow rate gives a higher value of tG/t0, which is potentially advantageous since 
resolution improves with (tG/t0)1/2. There is an optimum because higher flow rate will 
eventually decrease the plate number due to the mass transport term. To explore the 
optimum, higher flow rates, 25 and 50 μL/min, were studied for the 60 min gradient, and 
the chromatograms are shown in Figure 3B and 3C. The values of tg/t0 for these 
chromatograms in comparison to the slip flow chromatograms as well as mobile phase 
velocities, are summarized in Table 2, showing that these two chromatograms have linear 
flow rates exceeding that of the slip flow column by 2x and 4x, and that tG/t0 exceeds that 
of the slip flow column also by 2X and 4x. The result shows that resolution is negligibly 
affected by either flow rate or the variations in tG/t0. 
Dependence of chromatograms on column loading 
Before exploring a detailed comparison, it is worth checking both the dependence of the 
chromatograms of loading and the reproducibility of the chromatograms. This is 
important since the number of peaks change when gradient conditions change. Figure 4 
shows chromatograms for varying amounts injected. Equivalent amounts are injected into 
the respective columns, as they have 100x different cross-sectional areas. For both 
columns, more peaks are evident as the injected amount is increased. Again, this is likely 
from the nonlinearity of the electrospray process. 
Figure 5 shows replicate chromatograms for the two types of columns. The time axes 
have small shifts for both chromatograms, perhaps from the imprecision of the flow 
controls of each of the two chromatographs. The intensities also vary, as expected in 
using electrospray. Nonetheless, the differences among the replicates for a given column 
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are smaller than the differences between columns, allowing a comparison. The gradient 
optimization had shown that there are different peaks for different gradient conditions, 
whereas Figure 5 shows that a given gradient exhibits a set number of peaks and relative 
peak heights. Both are sufficiently reproducible for comparisons to be made. 
Extracted ion chromatograms for comparing resolution 
In studying column efficiency, any effect of partial overlap of peaks on the apparent peak 
capacity can be decreased by comparing extracted ion chromatograms. Figure 6 shows a 
comparison of the extracted ion chromatograms for the slip flow column for a 20 min 
gradient with tG/t0 =17 and the commercial column for a 60 min gradient and tG/t0=16. 
The peaks labeled 3 and 4, were fit to Gaussian to determine the standard deviations, and 
these were used to calculate the local peak capacities for just the core histones.  , which 
are x and y for the slip flow and commercial column, and the range of retention times for 
the peaks from H2B2 to H2A3, the peak capacity is 2 fold higher for the slip flow column. 
Further, Figure 6 shows that the width of the H4 peaks for the slip flow column is limited 
by the smoothing algorithm used to reduce electrospray noise, whereas this is not a 
limitation for the commercial column since it is broader. Specifically, the standard 
deviation of the H4 peak for the slip flow column is 1.56 s while the standard deviation of 
the smoothing function is 1.13 s, thus giving a 50% increase in the peak width. 
Considering this broadening, the peak capacity for the slip flow column is actually Z1 
fold higher than the commercial column. Regardless of whether the smoothing is taken 
into account, the slip flow column delivers higher resolution in addition to the three-fold 
faster separation time. 
CONCLUSION 
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Separation efficiency was studied for histones using a slip-flow capillary column with 
sub-0.5 μm nonporous silica particles for LCMS. The slip flow column gives both 2x 
higher peak capacity and 3x higher speed compared to columns that are three-fold longer. 
One such column has fully porous 5 μm particles and the other has 3.6 μm core-shell 
particles. In all cases, more peaks were observed as concentration increased presumably 
due to the nonlinearity of the electrospray process. The higher speed is a consequence of 
the column being shorter and the higher peak capacity is attributed to the number of 
plates being higher despite the shorter length. DFA was found to give better resolution 
than 0.5% formic acid with 0.02% TFA. Slow gradients can be used to further resolve the 
histones if analysis time is not considered as a limitation. This separation method can be 
applied on top-down proteomics of histones by coupling to higher resolution mass 
spectrometers to allow more detailed characterization for PTMs of histones in future. 
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